Exec Director, Global Commercial Product Strategy - Lenacapavir for Prevention

The Executive Director, Global Commercial Product Strategy for Lenacapavir for Prevention is responsible for shaping and leading the global commercial vision, strategy, and execution for one of Gilead’s most important long-acting‑ HIV prevention portfolio. This leader will oversee global commercial launch **of lenacapavir for HIV prevention** and guide early commercial planning for **future lenacapavir prevention assets** in the pipeline. The role drives cross functional‑ alignment, regional partnership, market development, and launch excellence to enable sustained global growth.* 15+ years of biopharmaceutical commercial experience, including extensive global or regional strategy leadership.* Proven experience leading cross functional teams and influencing‑ senior executive levels.* Experience working within or across multiple key markets* Demonstrated success in global launch planning, market development, or brand strategy for specialty or prevention focused‑ therapeutics.* Strong strategic thinking, analytical skills, and ability to translate insights into actionable strategies.* Excellent leadership, communication, and stakeholder management‑ capabilities.* HIV, infectious disease, or prevention ecosystem experience.* Consumer/Direct to Consumer experience.* Prior responsibility for evidence strategy, lifecycle planning, or shaping policy/market access environments.* Strategic agility and enterprise mindset* Cross functional‑ influence and decision leadership* Customer, market, and policy insight orientation* Inclusive people leadership and talent development* Ability to navigate ambiguity and drive clarity across complex global environments #J-18808-Ljbffr